Unknown PHASE4 INTERVENTIONAL 3-arm NCT04778813

Evaluation of Three Artemisinin-based Combinations for the Treatment of Uncomplicated Malaria in Childreen in Burkina Faso (CHIMIO2) (CHIMIO2)

Sponsor: Centre national de recherche et de formation sur le paludisme

Updated 4 times since 2021 Last updated: Feb 28, 2021 Started: Jun 1, 2021 Primary completion: Dec 31, 2021 Completion: Jun 1, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04778813, this PHASE4 trial focuses on Burkina Faso and Malaria and remains ongoing. Sponsored by Centre national de recherche et de formation sur le paludisme, it has been updated 4 times since 2021, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Mar 2023 — Jul 2024 [monthly]

Unknown Status PHASE4

Status: Not Yet Recruiting → Unknown Status
Apr 2021 — Mar 2023 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre national de recherche et de formation sur le paludisme
Programme national de lutte contre le paludisme (PNLP), Burkina Faso
USAID/IMPACT Malaria
Unité de recherche clinique de Nanoro (URCN)

Data source: Centre national de recherche et de formation sur le paludisme

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ouagadougou, Burkina Faso